Literature DB >> 10069362

Cyclooxygenase-dependent signalling: molecular events and consequences.

H H Versteeg1, P M van Bergen en Henegouwen, S J van Deventer, M P Peppelenbosch.   

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) currently attract large interest. Next to pain relief, NSAIDs have important anti-thrombotic and anti-oncogenic effects. NSAIDs exert their action by inhibition of cyclooxygenase, the enzyme responsible for the production of prostanoids. Prostanoid signal transduction is still poorly understood, but it has become clear that these inflammatory lipids influence cellular physiology at three different levels: (1) activation of a 7 x transmembrane receptor coupled to heterotrimeric G proteins, (2) the inhibition of inflammation by activating corticosteroid-like receptors, (3) participation in receptor protein tyrosine kinase signal transduction. In this review prostanoid signalling at these three different levels will be reviewed and the relevance in (patho)physiological processes will be evaluated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069362     DOI: 10.1016/s0014-5793(99)00105-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Present concepts on the inflammatory modulators with special reference to cytokines.

Authors:  A S J P A M Van Miert
Journal:  Vet Res Commun       Date:  2002-02       Impact factor: 2.459

Review 2.  Crosstalk of oncogenic and prostanoid signaling pathways.

Authors:  Rolf Müller
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

3.  Capnellene, a natural marine compound derived from soft coral, attenuates chronic constriction injury-induced neuropathic pain in rats.

Authors:  Yen-Hsuan Jean; Wu-Fu Chen; Chun-Sung Sung; Chang-Yih Duh; Shi-Ying Huang; Chan-Shing Lin; Ming-Hon Tai; Shun-Fen Tzeng; Zhi-Hong Wen
Journal:  Br J Pharmacol       Date:  2009-08-05       Impact factor: 8.739

4.  The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1.

Authors:  T L Yaksh; D M Dirig; C M Conway; C Svensson; Z D Luo; P C Isakson
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

5.  Blisters in the small intestinal mucosa of coeliac patients contain T cells positive for cyclooxygenase 2.

Authors:  H Kainulainen; I Rantala; P Collin; T Ruuska; H Päivärinne; T Halttunen; K Lindfors; K Kaukinen; M Mäki
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

6.  Transactivator protein BICP0 of bovine herpesvirus 1 (BHV-1) is blocked by prostaglandin D2 (PGD2), which points to a mechanism for PGD2-mediated inhibition of BHV-1 replication.

Authors:  Okay Saydam; Carlos Abril; Bernd Vogt; Mathias Ackermann; Martin Schwyzer
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  Chemopreventive and metabolic effects of inulin on colon cancer development.

Authors:  Emília Hijová; Viktória Szabadosova; Jana Štofilová; Gabriela Hrčková
Journal:  J Vet Sci       Date:  2013-06-30       Impact factor: 1.672

8.  Salidroside suppresses solar ultraviolet-induced skin inflammation by targeting cyclooxygenase-2.

Authors:  Dan Wu; Ping Yuan; Changshu Ke; Hua Xiong; Jingwen Chen; Jinguang Guo; Mingmin Lu; Yanyan Ding; Xiaoming Fan; Qiuhong Duan; Fei Shi; Feng Zhu
Journal:  Oncotarget       Date:  2016-05-03

9.  Variation in prostaglandin metabolism during growth of the diatom Thalassiosira rotula.

Authors:  Valeria Di Dato; Roberta Barbarinaldi; Alberto Amato; Federica Di Costanzo; Carolina Fontanarosa; Anna Perna; Angela Amoresano; Francesco Esposito; Adele Cutignano; Adrianna Ianora; Giovanna Romano
Journal:  Sci Rep       Date:  2020-03-25       Impact factor: 4.379

10.  Identification of Prostaglandin Pathway in Dinoflagellates by Transcriptome Data Mining.

Authors:  Valeria Di Dato; Adrianna Ianora; Giovanna Romano
Journal:  Mar Drugs       Date:  2020-02-13       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.